Title : Sodium-Glucose Co-Transporter 2 Inhibitors Compared with Sulfonylureas in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A Meta-Analysis of Randomized Controlled Trials.

Pub. Date : 2019 Jun

PMID : 31041606






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sodium-Glucose Co-Transporter 2 Inhibitors Compared with Sulfonylureas in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A Meta-Analysis of Randomized Controlled Trials. Metformin solute carrier family 5 member 2 Homo sapiens
2 This meta-analysis was to compare the efficacy and safety of sodium-glucose co-transporter 2 (SGLT2) inhibitors with sulfonylureas (SUs) as second-line therapy in patients with T2DM inadequately controlled on metformin. Metformin solute carrier family 5 member 2 Homo sapiens
3 CONCLUSIONS: Despite similar glycemic efficacy in a relatively short term, SGLT2 inhibitors are more effective in the longer term than SUs as add-on to metformin. Metformin solute carrier family 5 member 2 Homo sapiens